New drug tested for Tough-to-Treat kidney cancer
Disease control
Recruiting now
This early-stage study is testing a drug called orellanine in people with advanced kidney cancer that has spread. The main goals are to find a safe dose and see if the drug can shrink tumors. The study is for patients who are already on regular dialysis and have run out of other …
Phase: PHASE1, PHASE2 • Sponsor: Oncorena AB • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC